Barclays PLC Abcam PLC Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$21.54 - $24.41 $47 Million - $53.2 Million	2,180,006 Added 1061.89%	2,385,301 $54 Million
Q2 2023 Aug 03, 2023	BUY	$12.62 - $24.47 $2.5 Million - $4.84 Million	197,735 Added 2615.54%	205,295 $5.02 Million
Q4 2022 Feb 13, 2023	SELL	$13.92 - $17.0 $44,933 - $54,876	-3,228 Reduced 29.92%	7,560 $118,000
Q3 2022 Nov 03, 2022	SELL	$13.36 - $16.75 $1.03 Million - $1.29 Million	-77,175 Reduced 87.74%	10,788 $162,000
Q2 2022 Aug 12, 2022	BUY	$12.69 - $19.25 $949,935 - $1.44 Million	74,857 Added 571.17%	87,963 $1.27 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $203,143 - $313,102	13,106 New	13,106 $240,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.